Carrick Therapeutics Is A Clinical Stage Biopharmaceutical Company Based In Bostonspecializing In Oncologyfounded In 2016The Company Focuses On Developing Innovative Therapies For Aggressive And Treatment Resistant Cancerscarrick Emphasizes A Patient Centric Approach And Collaborates With Leading Cliniciansresearchersand Institutions Worldwide To Advance Its Research And Development Efforts The Company Operates As A Drug Development Entitymoving Therapies From Preclinical Stages Through Clinical Trialscarrick Actively Seeks Licensing Opportunities For Differentiated Assets And Engages In Collaborative Research To Translate Scientific Findings Into Clinical Applicationsits Pipeline Includes First In Class And Best In Class Therapies Targeting Various Cancer Driving Mechanismswith A Focus On Novel Molecules And Tailored Therapies Designed For Individual Patient Tumor Profiles Under The Leadership Of Ceo Drelaine Sullivancarrick Is Committed To Improving Patient Outcomes Through Precision Medicinethe Company Has Established New Headquarters In Boston To Support Its Growth And Continues To Pursue Partnerships To Enhance Its Oncology Focused Operations
